Hanall Biopharma Co., Ltd. - PE Ratio

The PE Ratio as of August 2026 (TTM) for Hanall Biopharma Co., Ltd. (009420.KS) is -551.49

According to Hanall Biopharma Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -551.49. This represents a change of -158.21% compared to the average of 947.47 of the last 4 quarters.

Hanall Biopharma Co., Ltd. (009420.KS) Historical PE Ratio (quarterly & annually)

How has 009420.KS PE Ratio performed in the past?

The mean historical PE Ratio of Hanall Biopharma Co., Ltd. over the last ten years is 412.27. The current -551.49 PE Ratio has changed -13476.82% with respect to the historical average. Over the past ten years (40 quarters), 009420.KS's PE Ratio was at its highest in in the March 2026 quarter at 2.55K. The PE Ratio was at its lowest in in the March 2022 quarter at -3070.99.

Hanall Biopharma Co., Ltd. (009420.KS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Hanall Biopharma Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Hanall Biopharma Co., Ltd. (009420.KS) Average PE Ratio

How has 009420.KS PE Ratio performed in the past?

The current PE Ratio of Hanall Biopharma Co., Ltd. (009420.KS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Hanall Biopharma Co., Ltd. (009420.KS) PE Ratio vs. Peers

How is 009420.KS’s PE Ratio compared to its peers?

Hanall Biopharma Co., Ltd.’s PE Ratio is less than Daewoong pharmaceutical Co.,Ltd (7.03), less than Oscotec Inc. (14.90), less than Celltrion Pharm, Inc. (42.82), less than ST Pharm Co.,Ltd. (26.97), less than D&D Pharmatech (-105.82), less than OliX Pharmaceuticals,Inc (-162.64), less than Chong Kun Dang Pharmaceutical Corp. (11.50), less than GC Biopharma Corp. (-27.91), less than DongKook Pharmaceutical Co., Ltd. (10.46), less than Ildong Pharmaceutical Co., Ltd. (8.25),

Build a custom stock screener for Hanall Biopharma Co., Ltd. (009420.KS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hanall Biopharma Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hanall Biopharma Co., Ltd. (009420.KS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hanall Biopharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.